APA (7th ed.) Citation

Colaneri, M., Genovese, C., Lombardi, A., Holmes, D., Bandera, A., & Gori, A. (2024). Carbapenem or new β-lactam-β-lactamase inhibitors? An Italian survey supported by SITA, SIMIT and SIAARTI to identify the factors affecting empiric antimicrobial therapy choice in real-life clinical practice. European Journal of Clinical Microbiology & Infectious Diseases, 43(5), 1017. https://doi.org/10.1007/s10096-024-04798-8

Chicago Style (17th ed.) Citation

Colaneri, Marta, Camilla Genovese, Andrea Lombardi, Darcy Holmes, Alessandra Bandera, and Andrea Gori. "Carbapenem or New β-lactam-β-lactamase Inhibitors? An Italian Survey Supported by SITA, SIMIT and SIAARTI to Identify the Factors Affecting Empiric Antimicrobial Therapy Choice in Real-life Clinical Practice." European Journal of Clinical Microbiology & Infectious Diseases 43, no. 5 (2024): 1017. https://doi.org/10.1007/s10096-024-04798-8.

MLA (9th ed.) Citation

Colaneri, Marta, et al. "Carbapenem or New β-lactam-β-lactamase Inhibitors? An Italian Survey Supported by SITA, SIMIT and SIAARTI to Identify the Factors Affecting Empiric Antimicrobial Therapy Choice in Real-life Clinical Practice." European Journal of Clinical Microbiology & Infectious Diseases, vol. 43, no. 5, 2024, p. 1017, https://doi.org/10.1007/s10096-024-04798-8.